feed,title,long_url,short_url
Benzinga,Alnylam Shares Detailed Patisiran Data From Rare Disease Study,https://benzinga.com/general/biotech/22/09/28795140/alnylam-shares-detailed-patisiran-data-from-rare-disease-study,https://bit.ly/3DbCHO8
Benzinga,After Initial Skepticism FDA's Adcomm Backs Amylyx's Amyotrophic Lateral Sclerosis Hopeful,https://benzinga.com/general/biotech/22/09/28795126/after-initial-skepticism-fdas-adcomm-backs-amylyxs-amyotrophic-lateral-sclerosis-hopeful,https://bit.ly/3Bzk85j
